Table 2. Relevant COVID-19 treatment and overall outcomes in patients with COVID-19 infection and large-vessel pathology.
Patient number | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
COVID-19 treatment | ||||||||
Hydroxychloroquine | No | No | No | No | Yes | No | No | Yes |
Tocilizumab | No | No | No | No | Yes | No | No | No |
Azithromycin | No | No | Yes | No | No | No | Yes | Yes |
Antibiotics | No | No | No | Yes | Yes | No | Yes | Yes |
Steroids | No | No | No | Yes | Yes | No | Yes | No |
Ascorbic acid | No | No | No | No | Yes | No | No | No |
Cholecalciferol | No | No | No | No | Yes | No | No | No |
Zinc sulfate | No | No | No | No | No | No | No | Yes |
Anticoagulation | No | No | No | No | Yes | No | Yes | No |
Vascular pathology imaging | Aortitis with multifocal pseudoaneurysms of thoracic aorta | Aortitis of distal thoracic aorta extending to proximal abdominal aorta | Segmental aortitis with rind of soft tissue thickening around infrarenal abdominal aorta | Vasculitis with diminished caliber of celiac trunk branch vessels, superior mesenteric artery, and renal arteries | Penetrating ulcer at distal aortic arch | Penetrating ulcer at proximal aortic arch | Right coronary artery aneurysm | Type A thoracoabdominal aortic dissection |
Vascular pathology treatment | Surgery | Medical (Steroids) | None | None | None | None | None | None |
Vascular pathology follow-up imaging | Resolved | Resolved | Persistent | N/A | Unknown | Unknown | Unknown | N/A |
Overall outcome | Alive | Alive | Alive | Expired | Alive | Alive | Alive | Expired |
Abbreviations: COVID-19, coronavirus disease 2019; N/A, not available.